Cure SMA, the leading nonprofit organization dedicated to supporting those impacted by spinal muscular atrophy (SMA), welcomes the FDA approval of Itvisma(tm) (onasemnogeneabeparvovec-brve) by Novartis for adults and children 2 years of age and older living with SMA and all types of SMA.
